methoxy polyethylene glycol-epoetin beta
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
erythropoiesis-stimulating agent |
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
gptkb:B03XA03
|
| gptkbp:brand |
gptkb:Mircera
|
| gptkbp:CASNumber |
914769-62-3
|
| gptkbp:developer |
gptkb:Roche
|
| https://www.w3.org/2000/01/rdf-schema#label |
methoxy polyethylene glycol-epoetin beta
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
erythropoietin receptor agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:sideEffect |
diarrhea
headache hypertension upper respiratory tract infection |
| gptkbp:usedFor |
treatment of anemia
anemia due to chronic kidney disease |
| gptkbp:bfsParent |
gptkb:Mircera
|
| gptkbp:bfsLayer |
8
|